Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002547117 | SCV000815500 | benign | Dyskeratosis congenita, autosomal dominant 2; Idiopathic Pulmonary Fibrosis | 2023-11-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004559356 | SCV002689827 | uncertain significance | Dyskeratosis congenita | 2022-02-02 | criteria provided, single submitter | clinical testing | The p.R342Q variant (also known as c.1025G>A), located in coding exon 2 of the TERT gene, results from a G to A substitution at nucleotide position 1025. The arginine at codon 342 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |